Hazem A. Ghabbour

Dr. Hazem A. Ghabbour

Medicinal Chemistry, Faculty of Pharmacy - Mansoura University, Al Manşūrah, Ad Daqahlīyah, Egypt
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2013 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
AAAbdulrahman Alsultan
Abdulrahman Alsultan
MAMohammed K. Alabdulaali
Mohammed K. Alabdulaali
PGPaula J. Griffin
Paula J. Griffin
AAAhmed M. AlSuliman
Ahmed M. AlSuliman
HGHazem A. Ghabbour
Hazem A. Ghabbour
MSMartin H Steinberg
Martin H Steinberg
Summary: Sickle cell disease (SCD) in Saudi patients from the Eastern Province is associated with the Arab‐Indian (AI) HBB (β‐globin gene) haplotype. The phenotype of AI SCD in children was described as benign and was attributed to their high fetal haemoglobin (HbF). We conducted a hospital‐based study to assess the pattern of SCD complications in adults. A total of 104 patients with average age of 27 years were enrolled. Ninety‐six per cent of these patients reported history of painful crisis; 47% had at least one episode of acute chest syndrome, however, only 15% had two or more episodes; symptomatic osteonecrosis was reported in 18%; priapism in 17%; overt stroke in 6%; none had leg ulcers. The majority of patients had persistent splenomegaly and 66% had gallstones. Half of the patients co‐inherited α‐thalassaemia and about one‐third had glucose‐6‐phosphate dehydrogenase deficiency. Higher HbF correlated with higher rate of splenic sequestration but not with other phenotypes. The phenotype of adult patients with AI SCD is not benign despite their relatively high HbF level. This is probably due to the continued decline in HbF level in adults and the heterocellular and variable distribution of HbF amongst F‐cells.

1 April 2018 in Bioorganic Chemistry
Verified
Journal Article
Closed access
Hadia AlmahliHadia Almahli
Hadia Almahli
EHElie Hadchity
Elie Hadchity
MJMaiy Y. Jaballah
Maiy Y. Jaballah
RDRacha Daher
Racha Daher
HGHazem A. Ghabbour
Hazem A. Ghabbour
WEWagdy M. Eldehna
Wagdy M. Eldehna

Verified
Journal Article
Open access
PDF file
KKKhalid Karrouchi
Khalid Karrouchi
YBYOUSFI El Bekkaye
YOUSFI El Bekkaye
NSNada Kheira SEBBAR
Nada Kheira SEBBAR
YRYoussef Ramli
Youssef Ramli
JTJamal Taoufik
Jamal Taoufik
SRSmaail Radi
Smaail Radi
The development of low-cost catalytic systems that mimic the activity of tyrosinase enzymes (Catechol oxidase) is of great promise for future biochemistry technologic demands. Herein, we report the synthesis of new biomolecules systems based on hydrazone derivatives containing a pyrazole moiety (L1–L6) with superior catecholase activity. Crystal structures of L1 and L2 biomolecules were determined by X-ray single crystal diffraction (XRD). Optimized geometrical parameters were calculated by density functional theory (DFT) at B3LYP/6–31G (d, p) level and were found to be in good agreement with single crystal XRD data. Copper (II) complexes of the compounds (L1–L6), generated in-situ, were investigated for their catalytic activities towards the oxidation reaction of catechol to ortho-quinone with the atmospheric dioxygen, in an attempt to model the activity of the copper containing enzyme tyrosinase. The studies showed that the activities depend on four parameters: the nature of the ligand, the nature of counter anion, the nature of solvent and the concentration of ligand. The Cu(II)-ligands, given here, present the highest catalytic activity (72.920 μmol·L−1·min−1) among the catalysts recently reported in the existing literature.

29 April 2017 in Molecules
Verified
Journal Article
Open access
PDF file
LALamya H. Al-Wahaibi
Lamya H. Al-Wahaibi
HHHanan Hafila
Hanan Hafila
AAAmal M. Abo-Kamar
Amal M. Abo-Kamar
HGHazem A. Ghabbour
Hazem A. Ghabbour
AEAli A. El-Emam
Ali A. El-Emam
A new series of adamantane-isothiourea hybrid derivatives, namely 4-arylmethyl (Z)-N′-(adamantan-1-yl)-morpholine-4-carbothioimidates 7a–e and 4-arylmethyl (Z)-N′-(adamantan-1-yl)-4-phenylpiperazine-1-carbothioimidates 8a–e were prepared via the reaction of N-(adamantan-1-yl)morpholine-4-carbothioamide 5 and N-(adamantan-1-yl)-4-phenylpiperazine-1-carbothioamide 6 with benzyl or substituted benzyl bromides, in acetone, in the presence of anhydrous potassium carbonate. The structures of the synthesized compounds were confirmed by 1H-NMR, 13C-NMR, electrospray ionization mass spectral (ESI-MS) data, and X-ray crystallographic data. The in vitro antimicrobial activity of the new compounds was determined against certain standard strains of pathogenic bacteria and the yeast-like pathogenic fungus Candida albicans. Compounds 7b, 7d and 7e displayed potent broad-spectrum antibacterial activity, while compounds 7a, 7c, 8b, 8d and 8e were active against the tested Gram-positive bacteria. The in vivo oral hypoglycemic activity of the new compounds was carried on streptozotocin (STZ)-induced diabetic rats. Compounds 7a, 8ab, and 8b produced potent dose-independent reduction of serum glucose levels, compared to the potent hypoglycemic drug gliclazide.

28 April 2015 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
HGHazem A. Ghabbour
Hazem A. Ghabbour
AKAdnan Kadi
Adnan Kadi
KEKamal E. H. ElTahir
Kamal E. H. ElTahir
RARihab F. Angawi
Rihab F. Angawi
HEHussein I. El-Subbagh
Hussein I. El-Subbagh

10 June 2016 in Molecules
Verified
Journal Article
Open access
PDF file
Wagdy Mohamed EldehnaWagdy Mohamed Eldehna
Wagdy Mohamed Eldehna
MMMohamed Fares Mahmoud Mohamed Metwaly
Mohamed Fares Mahmoud Mohamed Metwaly
HIHany Ibrahim
Hany Ibrahim
Maz AliMaz Ali
Maz Ali
MAMohamed H. Aly
Mohamed H. Aly
HAHatem Abdel-Aziz
Hatem Abdel-Aziz
In our endeavor towards the development of potent anticancer agents, two different sets of biphenylurea-indolinone conjugates, 5a–s and 8a,b were synthesized. The in vitro cytotoxicity of the synthesized compounds was examined in two human cancer cell lines, namely MCF-7 breast cancer and PC-3 prostate cancer cells using the sulforhodamine B (SRB) colorimetric assay. In particular, the MCF-7 cancer cell line was more susceptible to the synthesized compounds. Compound 5o (IC50 = 1.04 ± 0.10 μM) emerged as the most active member in this study against MCF-7, with 7-fold increased activity compared to the reference drug, doxorubicin (IC50 = 7.30 ± 0.84 μM). Compounds 5l, 5q and 8b also exhibited superior cytotoxic activity against MCF-7 with IC50 values of 1.93 ± 0.17, 3.87 ± 0.31 and 4.66 ± 0.42 μM, respectively. All of the tested compounds were filtered according to the Lipinski and Veber rules and all of them passed the filters. Additionally, several ADME descriptors for the synthesized compounds 5a–s and 8a,b were predicted via a theoretical kinetic study performed using the Discovery Studio 2.5 software.